Comparison of turbo-PUVA and conventional American-style PUVA in the treatment of psoriatic patients

Photodermatology Photoimmunology and Photomedicine

Volumn 26, Issue 4, 2010, Pages 205-210

  Moneib, Hoda Ahmed M ^a   Salem, Samar Aballah Mohamed ^a   Younis, Rehab Mohamed Mounir ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Dihydroxyacetone; Psoriasis; Treatment; Turbo PUVA

Indexed keywords

ADOLESCENT; ADULT; AGED; AMERICAN STYLE PUVA; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION DOSE; REMISSION; SKIN; TREATMENT DURATION; TURBO PUVA; ULTRAVIOLET A RADIATION; COMPARATIVE STUDY; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PSORIASIS; PUVA THERAPY; YOUNG ADULT;

PHOTOSENSITIZING AGENT;

EID: 77954710510     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2010.00523.x     Document Type: Article

References (33)

1. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004, 9:136-139.
2. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001, 137:280-284.
3. Zachariae R, Zachariae CO, Lei U, Pedersen AF. Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol 2008, 88:121-127.
4. Christophers E, Mrowietz U. Psoriasis. Fitzpatrick's dermatology in general medicine 2003, 407-427. Freedberg IM, Eizen AZWolff KAusten KFGoldsmith LAKatz SI. In, eds, 6th edn, New York, McGraw-Hill
5. Gattu S, Pang ML, Pugashetti R. Pilot evaluation of supra-erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis. J Dermatolog Treat 2009, 1:1-7. (Epub ahead of print)
6. Taylor CR, Kwangsukstith C, Wimberly J, Kollias N, Anderson RR. Turbo-PUVA: dihydroxyacetone-enhanced photochemotherapy for Psoriasis: a pilot study. Arch Dermatol 1999, 135:540-544.
7. Levy SB. Dermatologic aspects of cosmetics: tanning preparations. Dermatol Clin 2000, 18:591-596.
8. Morison WL. PUVA photochemotherapy 1993, Lim HWSoter NA. In, eds, New York, Marcel Dekker
9. Zanolli MD, Feldman SR. Phototherapy treatment protocols for psoriasis and other phototherapy responsive dermatoses 2004, 2nd ed, New York, Informa Healthcare
10. Levy SB. Cosmetics that imitate a tan. Dermatol Ther 2001, 14:215-219.
11. Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978, 157:238-244.
12. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999, 141:185-191.
13. Varma S, Ballambat SP, Balachandran C, Shenoi SD, Prabhu S. Clothes-on PUVA in psoriasis: single blind randomized comparative trial on 21 patients. Indian J Dermatol Venereol Leprol 2004, 70:152-155.
14. Granstein RD, Matsui MS. UV radiation-induced immunosuppression and skin cancer. Cutis 2004, 74((Suppl. 5)):4-9.
15. Hruza L, Kollias N, Wimberly J, Anderson R. Dihydroxyacetone-enhanced PUVA. Presented at Annual Meeting of the 1994; 17 March; Washington, DC
16. Petersen AB, Na R, Wulf HC. Sunless skin tanning with dihydroxyacetone delays broad-spectrum ultraviolet photocarcinogenesis in hairless mice. Mutat Res 2003, 542:129-138.
17. Gasparro FP. Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy. Environ Health Perspect 2000, 108((Suppl. l)):71-78.
18. http://www.fda.gov/OHRMS/DOCKETS/98fr/07-4131.pdf, Sunscreen Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph. Department of Health and Human Services, Food and Drug Administration, 21 CFR Parts 347 and 352 [Docket No. 1978N-0038] (formerly Docket No. 78N-0038), RIN 0910-AF43, Federal Register: August 27, 2007; 72(165): 49069-49122, Last accessed April 12, 2010
19. Choquenet B, Couteau C, Paparis E, Coiffard LJM. Foundations and self-tanning products: do they provide any protection from the sun? Journal of Dermatology 2009, 36:587-591.
20. Valkova S. UVB phototherapeutic modalities. Comparison of two treatments for chronic plaque psoriasis. Acta Dermatovenerol Alp Panonica Adriat 2007, 16:26-30.
21. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL. Oral methoxsalen photo-chemotherapy for treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol 1977, 68:328-335. 28 participating investigators.
22. Lindelöf B, Sigurgeirsson B, Tegner E. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 1999, 141:108-112.
23. McKenna KE. Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients. Photodermatol Photoimmunol Photomed 2004, 20:289-296.
24. Nguyen BC, Kochevar IE. Factors influencing sunless tanning with dihydroxyacetone. Br J Dermatol 2003, 149:332-340.
25. El-Mofty M, El Weshahy H, Youssef R, Abdel-Halim M, Mashaly H, El Hawary M. A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study). Photodermatol Photoimmunol Photomed 2008, 24:38-42.
26. Sakuntabhai A, Sharpe GR, Farr PM. Response of psoriasis to twice weekly PUVA. Br J Dermatol 1993, 128:166-171.
27. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001, 45:487-498.
28. Legat FJ, Hofer A, Quehenberger F, Kahofer P, Kerl H, Wolf P. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA. J Am Acad Dermatol 2004, 51:746-754.
29. Hofer A, Fink-Puches R, Kerl H, Wolf P. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol 1998, 138:96-100.
30. Rogers S, Marks J, Shuster S. Itch following photochemotherapy for psoriasis. Acta Derm Venereol 1981, 61:178-180.
31. Griffiths CEM, Camp RDR, Barker JNWN. Psoriasis. Rook's textbook of dermatology 2004, 35.1-35.69. Burns DA, Breathnach SM, Cox NHGriffiths CEM. In, eds, 7th edn, London, Blackwell Science Ltd
32. Petersen AB, Wulf HC, Gniadecki R, Gajkowska B. Dihydroxyacetone, the active browning ingredient in sunless tanning lotions, induces DNA damage, cell-cycle block and apoptosis in cultured HaCaT keratinocytes. Mutat Res 2004, 560:173-186.
33. Jung K, Seifert M, Herrling T, Fuchs J. UV-generated free radicals (FR) in skin: their prevention by sunscreens and their induction by self-tanning agents. Spectrochim Acta A Mol Biomol Spectrosc 2008, 69:1423-1428.